Tobacco Use Disorder
346
26
35
252
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
116 trials with published results (34%)
Research Maturity
252 completed trials (73% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
3.5%
12 terminated out of 346 trials
95.5%
+8.9% vs benchmark
11%
39 trials in Phase 3/4
46%
116 of 252 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 252 completed trials
Clinical Trials (346)
Effect of Teleconsultation Counseling on Smoking Cessation
Project Q: Cue-based Treatment Intervention to Promote Cessation Among People Who Smoke Lightly or Non-daily
A Behavioral Activation Prenatal and Postpartum Intervention for Depressed Pregnant Smokers
Evaluation of the Efficacy of QUITOXIL® in Smoking Cessation
Impact of Novel vs. Usual Brand Menthol Cigarettes on Abuse Liability
Varenicline for Smoking Reduction in Veterans Not Ready To Quit
Abstinence Reinforcement Therapy for Veterans Who Smoke Tobacco and Are Experiencing Homelessness
PARQuit Smoking Cessation Intervention for Adults With Serious Mental Illness
Feasibility of a Medical-Legal Partnership Model to Connect Coal Miners QuitAid
Computer Game, Qualitative, and MEG/EEG Assessment of Serotonergic Psychedelics
Young Adult Tobacco/Nicotine and Cannabis Co-use
5-HT2A Agonist Psilocybin in the Treatment of Tobacco Use Disorder
LaunchPad: Supporting Healthy Decisions and Preventing Drug Use After High School
E-cigarette Cessation in Adults Who Co-use Cannabis
Behavioral Activation Therapy and Nicotine Replacement Therapy in Increasing Smoking Cessation
THCV Treatment for Smokers
Omega-3 Fatty Acids for Smoking Cessation in Pregnancy
Chatbot for Online Support Groups to Treat Tobacco Addiction
Project 4, Study 2: Extended Exposure to Low Nicotine Content Cigarettes in Pregnant Women
Smartphone-based Financial Incentives